Pseudocholinesterase-Activity Reduction during Cardiopulmonary Bypass - increased sensitivity by adding purified antithrombin III

Author： Rump A.F.E.   Schierholz J.   Biederbick W.   Theisohn M.   Diefenbach C.   Abel M.   Borner U.   Buzello W.   Klaus W.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.32, Iss.1, 1999-01, pp. : 65-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Importance of Pulmonary Artery Circulation during Cardiopulmonary Bypass

By Ege T   Canbaz S   Cikirikcioglu M   Arar C   Edis M   Duran E  

The Journal of International Medical Research, Vol. 31, Iss. 1, 2003-01 ,pp. : 17-25

Field House Publishing

Access to resources Recommend Favorite

Direct Measurement of Nitric Oxide during Experimental Cardiopulmonary Bypass

By Hamanaka S   Tanemoto K   Inagaki E   Yamasawa T   Yoshida K   Mochizuki S   Goto M   Miyasaka T   Kajiya F   Tanaka N  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 295-300

Field House Publishing

Access to resources Recommend Favorite

Heat Shock Proteins and Myocardial Protection during Cardiopulmonary Bypass

By Yavuz S   Kasap M   Parlar H   Agirbas H   Torol S   Kanli A   Hosten T   Kanko M   Berki T  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 499-507

Field House Publishing

Access to resources Recommend Favorite

Antithrombin III: no benefit in severe sepsis

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Recombinant Human Antithrombin III: rhATIII

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 110-112

Adis International

Access to resources Recommend Favorite